Shares outstanding increased 44.6%
Shares outstanding changed +44.6% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +44.6% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
Operating cash flow changed +22.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating income changed +15.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -65.3% from the comparable as-filed period.
Total assets changed -48.2% from the comparable as-filed period.
Current assets changed -48.6% from the comparable as-filed period.
Current ratio changed -48.7% from the comparable as-filed period.
Working capital changed -58.4% from the comparable as-filed period.
Working capital / assets changed -1592 basis points from the comparable as-filed period.
Research & development changed -6.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +8.2% from the comparable as-filed period.
Current liabilities changed +0.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.